Cell line · CVCL_1167
Daoy
Cancer cell line, Homo sapiens. Medulloblastoma, SHH-activated, TP53-mutant. 51 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Daoy. Cell lines, record CVCL_1167. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1167
On this page
Cell line
As Cellosaurus gives it.
- Name
- Daoy
- Accession
- CVCL_1167
- RRID
- RRID:CVCL_1167
- Synonyms
- DAOY, D324 Med, D-324 Med, D324 MED, D-324MED, D324
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 4Y
- Category
- Cancer cell line
- Diseases
- Medulloblastoma, SHH-activated, TP53-mutant (NCIt C129442); Medulloblastoma (ORDO Orphanet_616)
- Derived from
- Brain, posterior fossa (in situ)
- Secondary accessions
- CVCL_7903
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers51
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| 18β-Glycyrrhetinic Acid Exerts Subgroup-Specific Antitumor Activity and Enhances Radiosensitivity in Medulloblastoma. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The MALAT1-EZH2 axis regulates PRC2 activity and promotes the mesenchymal phenotype in pediatric atypical teratoid/rhabdoid tumors. | J Neurooncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| 7,7"-dimethoxyagastisflavone induced MYCN/MYBL2-dependent apoptosis and metabolism reprogramming in Sonic Hedgehog medulloblastoma. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Detection of structural DNA variants in medulloblastomas using optical genome mapping. | Acta Neuropathol Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Exploring the prognostic molecular mechanisms of medulloblastoma through methylation-transcriptome integration. | SAGE Open Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GPC6 facilitates progression of SHH-subgroup medulloblastoma by enhancing Hedgehog secretion and signaling responses. | J Biomed Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Recombinant Monoclonal Antibodies for Detecting the Tubulin Post-Translational Modifications Glutamylation and Lysine-40 Acetylation. | Cytoskeleton (Hoboken) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 51
See all 51 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Daoy EZHIP KO | CVCL_C8V5 | Cell lines | |
| Derived from it | Daoy-luc2-tdT | CVCL_A9DF | Cell lines |
Cell banks6
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-186 | ATCC | |
| BCRJ | 0325 | BCRJ | |
| CLS | 305053 | CLS | |
| Hysigen | TCH-C166 | Hysigen | |
| KCB | KCB 2010203YJ | Cellosaurus | |
| NCBI_Iran | C519 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1167
GET https://conductscience.org/api/cell-lines/v1/CVCL_1167/papers?page=2